Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience
Yıl: 2019 Cilt: 49 Sayı: 1 Sayfa Aralığı: 222 - 229 Metin Dili: İngilizce DOI: 10.3906/sag-1807-295 İndeks Tarihi: 08-05-2020
Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience
Öz: Background/aim: The HIV-infected population is aging, and the concomitant comorbidities increase the likelihood of polypharmacy.There is a scarcity of data for determining drug-related problems in people living with HIV/AIDS (PLWHA).Materials and methods: This cross-sectional study was carried out between 1 September 2015 and 1 July 2016. All patients underwenta face-to-face interview with a clinical pharmacist. PCNE Classification V 7.0 was used classify incident drug-related problems (DRPs).Results: The mean age of the patients was 40.4 ± 13.06 years. The rate of polypharmacy was 66.1% in patients with comorbidities and12.3% in those without comorbidities (P < 0.001). DRPs were more prominent in older patients (46 vs. 37 years, P < 0.001), those withlonger durations of antiretroviral therapy (ART) (45 vs. 27 months, P = 0.014), and those with lower education levels (P = 0.013).Receiving >3 ART drugs was associated with more DRPs in the logistic regression model (odds ratio: 8.299, 95% confidence interval:1.924–35.803). Fifty-eight interventions were performed in 45 (24.9%) patients. Clinical pharmacist interventions were performed in18.9% of patients without polypharmacy and in 38.9% of patients with polypharmacy (P < 0.001).Conclusion: DRPs and polypharmacy are common among elderly PLWHA. More interventions are warranted to boost the quality oflife in aging PLWHA.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Duyan V, Yildirim G. A brief picture of HIV/AIDS in Turkey. AIDS Patient Care STDS 2003; 17: 373-375.
- 2. Marcus JL, Chao CR, Leyden WA, Xu L, Quesenberry CP Jr, Klein DB, Towner WJ, Horberg MA, Silverberg MJ. Narrowing the gap in life expectancy between HIV-infected and HIVuninfected individuals with access to care. J Acquir Immune Defic Syndr 2016; 73: 39-46.
- 3. Guaraldi G, Menozzi M, Zona S, Calcagno A, Silva AR, Santoro A, Malagoli A, Dolci G, Mussi C, Mussini C et al. Impact of polypharmacy on antiretroviral prescription in people living with HIV. J Antimicrob Chemother 2017; 72: 511-514.
- 4. Cantudo-Cuenca MR, Jimenez-Galan R, Almeida-Gonzalez CV, Morillo-Verdugo R. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients. J Manag Care Spec Pharm 2014; 20: 844-850.
- 5. Edelman EJ, Gordon KS, Glover J, McNicholl IR, Fiellin DA, Justice AC. The next therapeutic challenge in HIV: polypharmacy. Drugs Aging 2013; 30: 613-628.
- 6. Basger BJ, Moles RJ, Chen TF. Application of drug-related problem (DRP) classification systems: a review of the literature. Eur J Clin Pharmacol 2014; 70: 799-815.
- 7. Hsu WT, Shen LJ, Lee CM. Drug-related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management. J Formos Med Assoc 2016; 115: 335-342.
- 8. Kheshti R, Aalipour M, Namazi S. A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness. J Res Pharm Pract 2016; 5: 257- 263.
- 9. Sutaria A, Liu L, Ahmed Z. Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective. Ther Adv Cardiovasc Dis 2016; 10: 242-250.
- 10. Eginger KH, Yarborough LL, Inge LD, Basile SA, Floresca D, Aaronson PM. Medication errors in HIV-infected hospitalized patients: a pharmacist’s impact. Ann Pharmacother 2013; 47: 953-960.
- 11. Pastakia SD, Corbett AH, Raasch RH, Napravnik S, Correll TA. Frequency of HIV-related medication errors and associated risk factors in hospitalized patients. Ann Pharmacother 2008; 42: 491-497.
- 12. Erlandson KM, Allshouse AA, Jankowski CM, Duong S, MaWhinney S, Kohrt WM, Campbell TB. Risk factors for falls in HIV-infected persons. J Acquir Immune Defic Syndr 2012; 61: 484-489.
- 13. Marzolini C, Back D, Weber R, Furrer H, Cavassini M, Calmy A, Vernazza P, Bernasconi E, Khoo S, Battegay M et al. Ageing with HIV: medication use and risk for potential drug-drug interactions. J Antimicrob Chemother 2011; 66: 2107-2111.
- 14. Nachega JB, Hsu AJ, Uthman OA, Spinewine A, Pham PA. Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population. AIDS 2012; 26: S39-S53.
- 15. Krentz HB, Cosman I, Lee K, Ming JM, Gill MJ. Pill burden in HIV infection: 20 years of experience. Antivir Ther 2012; 17: 833-840.
- 16. Holtzman C, Armon C, Tedaldi E, Chmiel JS, Buchacz K, Wood K, Brooks JT; HOPS Investigators. Polypharmacy and risk of antiretroviral drug interactions among the aging HIVinfected population. J Gen Intern Med 2013; 28: 1302-1310.
- 17. Tseng A, Szadkowski L, Walmsley S, Salit I, Raboud J. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients. Ann Pharmacother 2013; 47: 1429-1439.
- 18. Molino Cde G, Carnevale RC, Rodrigues AT, Visacri MB, Moriel P, Mazzola PG. Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection. Ther Clin Risk Manag 2014; 10: 631-639.
- 19. Silveira MP, Guttier MC, Page K, Moreira LB. Randomized controlled trial to evaluate the impact of pharmaceutical care on therapeutic success in HIV-infected patients in Southern Brazil. AIDS Behav 2014; 18: S75-S84.
- 20. Foisy MM, Akai PS. Pharmaceutical care for HIV patients on directly observed therapy. Ann Pharmacother 2004; 38: 550- 556.
- 21. Walji N, Beardsell A, Brown G. Pharmacists’ activities in monitoring zidovudine therapy in an AIDS clinic. Can J Hosp Pharm 1992; 45: 29-32.
- 22. Bozek PS, Perdue BE, Bar-Din M, Weidle PJ. Effect of pharmacist interventions on medication use and cost in hospitalized patients with or without HIV infection. Am J Health Syst Pharm 1998; 55: 1151-1155.
- 23. Carcelero E, Tuset M, Martin M, De Lazzari E, Codina C, Miro J, Gatell J. Evaluation of antiretroviral-related errors and interventions by the clinical pharmacist in hospitalized HIV-infected patients. HIV Med 2011; 12: 494-499.
- 24. Billedo JA, Berkowitz LB, Cha A. Evaluating the impact of a pharmacist-led antiretroviral stewardship program on reducing drug interactions in HIV-infected patients. J Int Assoc Provid AIDS Care 2016; 15: 84-88.
- 25. Ojeh VB, Naima N, Abah IO, Falang KD, Lucy O, London I, Dady C, Agaba P, Agbaji O. Pattern of drug therapy problems and interventions in ambulatory patients receiving antiretroviral therapy in Nigeria. Pharm Pract (Granada) 2015; 13: 566.
| APA | Kara E, İNKAYA A, AYDIN HAKLI D, DEMİRKAN S, ÜNAL S (2019). Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience. , 222 - 229. 10.3906/sag-1807-295 |
| Chicago | Kara Emre,İNKAYA AHMET ÇAĞKAN,AYDIN HAKLI DUYGU,DEMİRKAN SALİH KUTAY,ÜNAL Serhat Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience. (2019): 222 - 229. 10.3906/sag-1807-295 |
| MLA | Kara Emre,İNKAYA AHMET ÇAĞKAN,AYDIN HAKLI DUYGU,DEMİRKAN SALİH KUTAY,ÜNAL Serhat Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience. , 2019, ss.222 - 229. 10.3906/sag-1807-295 |
| AMA | Kara E,İNKAYA A,AYDIN HAKLI D,DEMİRKAN S,ÜNAL S Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience. . 2019; 222 - 229. 10.3906/sag-1807-295 |
| Vancouver | Kara E,İNKAYA A,AYDIN HAKLI D,DEMİRKAN S,ÜNAL S Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience. . 2019; 222 - 229. 10.3906/sag-1807-295 |
| IEEE | Kara E,İNKAYA A,AYDIN HAKLI D,DEMİRKAN S,ÜNAL S "Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience." , ss.222 - 229, 2019. 10.3906/sag-1807-295 |
| ISNAD | Kara, Emre vd. "Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience". (2019), 222-229. https://doi.org/10.3906/sag-1807-295 |
| APA | Kara E, İNKAYA A, AYDIN HAKLI D, DEMİRKAN S, ÜNAL S (2019). Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience. Turkish Journal of Medical Sciences, 49(1), 222 - 229. 10.3906/sag-1807-295 |
| Chicago | Kara Emre,İNKAYA AHMET ÇAĞKAN,AYDIN HAKLI DUYGU,DEMİRKAN SALİH KUTAY,ÜNAL Serhat Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience. Turkish Journal of Medical Sciences 49, no.1 (2019): 222 - 229. 10.3906/sag-1807-295 |
| MLA | Kara Emre,İNKAYA AHMET ÇAĞKAN,AYDIN HAKLI DUYGU,DEMİRKAN SALİH KUTAY,ÜNAL Serhat Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience. Turkish Journal of Medical Sciences, vol.49, no.1, 2019, ss.222 - 229. 10.3906/sag-1807-295 |
| AMA | Kara E,İNKAYA A,AYDIN HAKLI D,DEMİRKAN S,ÜNAL S Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience. Turkish Journal of Medical Sciences. 2019; 49(1): 222 - 229. 10.3906/sag-1807-295 |
| Vancouver | Kara E,İNKAYA A,AYDIN HAKLI D,DEMİRKAN S,ÜNAL S Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience. Turkish Journal of Medical Sciences. 2019; 49(1): 222 - 229. 10.3906/sag-1807-295 |
| IEEE | Kara E,İNKAYA A,AYDIN HAKLI D,DEMİRKAN S,ÜNAL S "Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience." Turkish Journal of Medical Sciences, 49, ss.222 - 229, 2019. 10.3906/sag-1807-295 |
| ISNAD | Kara, Emre vd. "Polypharmacy and drug-related problems among people living with HIV/AIDS: a singlecenter experience". Turkish Journal of Medical Sciences 49/1 (2019), 222-229. https://doi.org/10.3906/sag-1807-295 |
